Mucignat V, Ducrocq S, Lebas F, Mochel F, Baudon J J, Gold F
Service de néonatologie, hôpital Armand-Trousseau, AP-HP, 26, avenue du Dr-Arnold-Netter, 77571 Paris cedex 12, France.
Arch Pediatr. 2004 Aug;11(8):921-5. doi: 10.1016/j.arcped.2004.03.028.
To compare the analgesic effects of non nutritive pacifier sucking, oral administration of a 30% saccharose solution, local application of Emla and their association for subcutaneous injection of erythropoietin (EPO) in preterm infants.
Our study was a randomised, prospective study conducted over 5 months. Neonates with a gestational age below 33 weeks of gestation and older than 8 days of life were included if they were treated with EPO (three subcutaneous injections per week during 6 weeks). For each consecutive EPO injection, patients were randomised between four groups of intervention: non nutritive pacifier sucking (T), oral administration of 0.2-0.5 ml of a 30% saccharose solution with non nutritive pacifier sucking (S), local application of Emla with non nutritive pacifier sucking (E), and oral administration of 0.2-0.5 ml of a 30% saccharose solution with local application of Emla and with non nutritive pacifier sucking (S + E). Each child was its own control. Pain was assessed with the Newborn Acute Pain scale (DAN) and with the Neonatal Facial Coding System (NFCS).
Thirty-three neonates were included, representing 265 injections. Distribution was: 41 in group T, 71 in group E, 86 in group S and 67 in group E + S. Mean DAN and NFCS scores were statistically different between groups T, E and S. Analgesic effect of saccharose (-1.05) was greater than Emla (-0.56). Used together, effects were adding up without potentialisation.
This study shows that the association of non nutritive pacifier sucking with oral administration of saccharose and local application of Emla has a better analgesic effect than each of these three interventions alone for subcutaneous injection of EPO.
比较非营养性安抚奶嘴吸吮、口服30%蔗糖溶液、局部应用复方利多卡因凝胶(Emla)及其联合使用对早产儿皮下注射促红细胞生成素(EPO)的镇痛效果。
我们的研究是一项为期5个月的随机前瞻性研究。纳入孕周小于33周且出生后8天以上、接受EPO治疗(6周内每周皮下注射3次)的新生儿。对于每一次连续的EPO注射,患者被随机分为四组干预措施:非营养性安抚奶嘴吸吮(T组)、口服0.2 - 0.5 ml 30%蔗糖溶液并同时吸吮非营养性安抚奶嘴(S组)、局部应用Emla并同时吸吮非营养性安抚奶嘴(E组)、口服0.2 - 0.5 ml 30%蔗糖溶液且局部应用Emla并同时吸吮非营养性安抚奶嘴(S + E组)。每个孩子自身作为对照。采用新生儿急性疼痛量表(DAN)和新生儿面部编码系统(NFCS)评估疼痛。
纳入33例新生儿,共进行了265次注射。分组情况为:T组41次,E组71次,S组86次,E + S组67次。T组、E组和S组之间的平均DAN和NFCS评分在统计学上存在差异。蔗糖的镇痛效果(-1.05)大于Emla(-0.56)。联合使用时,效果相加而无增效作用。
本研究表明,对于皮下注射EPO,非营养性安抚奶嘴吸吮联合口服蔗糖和局部应用Emla的镇痛效果优于这三种干预措施单独使用时的效果。